PIK3CA and breast neoplasm: MassARRAY analysis was used to identify hot spot mutations in PIK3CA, EGFR, ERBB2, ERBB3 and ERBB4. PIK3CA mutations alone were detected in 15 breast tumour samples (20.3%), whereas EGFR mutations alone were detected in 2 samples (2.7%).